Cystoid Macular Edema Clinical Trials
A listing of Cystoid Macular Edema medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 35 clinical trials
A Study to Investigate RO7200220 in Diabetic Macular Edema
of RO7200220 administered intravitreally in participants with diabetic macular edema. Only one eye will be chosen as the study eye. The duration of the study will be up to 76 weeks.
- 26 views
- 03 Apr, 2023
- 79 locations
A Study to Investigate RO7200220 in Combination With Ranibizumab in Diabetic Macular Edema
pharmacodynamics (PD) of RO7200220 in combination with, anti-vascular endothelial growth factor (VEGF) inhibitor, ranibizumab compared with ranibizumab alone in participants with diabetic macular edema. Only one
- 2 views
- 07 Apr, 2023
- 42 locations
Home Monitoring of Diabetic Macular Edema
Diabetic macular edema (DME) is part of diabetic retinopathy (DR) and a leading cause of central visual loss in people with diabetes . Most patients require pharmacological inhibition using anti
- 0 views
- 06 Apr, 2023
- 1 location
RO7200220 in Participants With Uveitic Macular Edema (Sandcat)
This study will assess the efficacy and safety of RO7200220 in participants with uveitic macular edema.
- 0 views
- 10 Apr, 2023
- 4 locations
Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema (PRO-169)
Phase III clinical study to evaluate the efficacy, expressed as improvement in visual acuity in patients suffering diabetic macular edema after one year of treatment with PRO-169, compared to
- 0 views
- 07 Oct, 2022
- 1 location
A Study to Investigate RO7200220 in Participants With Uveitic Macular Edema (Meerkat)
This study will assess the efficacy and safety of RO7200220 in participants with uveitic macular edema.
- 0 views
- 11 Apr, 2023
- 13 locations
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
The objective of this trial is to assess the safety, efficacy, and tolerability of RZ402 in patients with Diabetic Macular Edema.
- 0 views
- 09 Apr, 2023
Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema (EMMA)
Diabetic macular oedema (DME) is the main cause of visual impairment (or visual acuity) in patients with diabetic retinopathy, as it leads to progressive thickening of the retina, which in the
- 0 views
- 07 Oct, 2022
- 1 location
A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema (ELEVATUM)
This study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treated with faricimab. The study population will
- 7 views
- 08 Apr, 2023
- 38 locations
Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects With Diabetic Macular Edema
untreated, clinically significant, diabetic macular edema (DME).
- 0 views
- 12 Apr, 2023
- 1 location